- Home
- DSGN vs OIA Comparison
DSGN vs OIA Comparison
Compare DSGN & OIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- OIA
- Stock Information
- Founded
- DSGN 2017
- OIA 1988
- Country
- DSGN United States
- OIA United States
- Employees
- DSGN N/A
- OIA N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- OIA Finance Companies
- Sector
- DSGN Health Care
- OIA Finance
- Exchange
- DSGN Nasdaq
- OIA Nasdaq
- Market Cap
- DSGN 348.2M
- OIA 287.4M
- IPO Year
- DSGN 2021
- OIA N/A
- Fundamental
- Price
- DSGN $4.87
- OIA $6.09
- Analyst Decision
- DSGN Hold
- OIA
- Analyst Count
- DSGN 3
- OIA 0
- Target Price
- DSGN $7.00
- OIA N/A
- AVG Volume (30 Days)
- DSGN 220.6K
- OIA 97.9K
- Earning Date
- DSGN 03-18-2025
- OIA 01-01-0001
- Dividend Yield
- DSGN N/A
- OIA 4.88%
- EPS Growth
- DSGN N/A
- OIA N/A
- EPS
- DSGN N/A
- OIA N/A
- Revenue
- DSGN N/A
- OIA N/A
- Revenue This Year
- DSGN N/A
- OIA N/A
- Revenue Next Year
- DSGN N/A
- OIA N/A
- P/E Ratio
- DSGN N/A
- OIA N/A
- Revenue Growth
- DSGN N/A
- OIA N/A
- 52 Week Low
- DSGN $2.25
- OIA $4.93
- 52 Week High
- DSGN $7.77
- OIA $6.72
- Technical
- Relative Strength Index (RSI)
- DSGN 42.19
- OIA 49.73
- Support Level
- DSGN $3.71
- OIA $5.90
- Resistance Level
- DSGN $6.81
- OIA $6.01
- Average True Range (ATR)
- DSGN 0.50
- OIA 0.07
- MACD
- DSGN -0.10
- OIA 0.03
- Stochastic Oscillator
- DSGN 37.42
- OIA 93.33
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About OIA Invesco Municipal Income Opportunities Trust
Invesco Muni Income Opps Trust operates as a diversified closed-end management investment company. Its investment objective is to provide a high level of current income which is exempt from federal income tax.